Charles Cherington 13D and 13G filings for Eterna Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-11 8:39 pm Purchase |
2025-06-09 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 2,779,385 37.900% |
1,417,209 (+104.04%) |
Filing |
| 2025-04-04 10:55 am Purchase |
2025-04-02 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 1,362,176 32.800% |
252,697 (+22.78%) |
Filing |
| 2025-03-05 5:55 pm Purchase |
2024-10-29 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 1,109,479 32.380% |
1,028,644 (+1272.52%) |
Filing |
| 2023-12-22 12:05 pm Unchanged |
2023-12-14 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 80,835 19.990% |
0 (Unchanged) |
Filing |
| 2023-09-07 5:26 pm Purchase |
2023-07-13 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 80,835 19.990% |
43,000 (+113.65%) |
Filing |
| 2022-12-14 4:30 pm Purchase |
2022-12-02 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 37,835 11.050% |
37,835 (New Position) |
Filing |